Product News from the 11/07/06 News Brief

Share this article:
The FDA has approved the first generic version of Galderma’s MetroGel-Vaginal (metronidazole), a treatment for bacterial vaginosis. The generic version, Metronidazole Vaginal Gel, is manufactured by QLT of Fort Collins, CO. The company is eligible for 180 days of generic drug exclusivity. NovaDel Pharma said its NitroMist (nitroglycerin lingual aerosol) has been approved by the FDA for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. North American commercial rights for NitroMist have been licensed to Par Pharmaceutical.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters